Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AIDS Malignancy Consortium
Instituto do Cancer do Estado de São Paulo
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)